Overexpression of LIM and SH3 Protein 1 leading to accelerated G2/M phase transition contributes to enhanced tumourigenesis in oral cancer
about
LASP1, a Newly Identified Melanocytic Protein with a Possible Role in Melanin Release, but Not in Melanoma ProgressionAn update on the LIM and SH3 domain protein 1 (LASP1): a versatile structural, signaling, and biomarker proteinWWP2 is overexpressed in human oral cancer, determining tumor size and poor prognosis in patients: downregulation of WWP2 inhibits the AKT signaling and tumor growth in mice.Molecular characterization of LASP-1 expression reveals vimentin as its new partner in human hepatocellular carcinoma cells.ANGPTL3 is a novel biomarker as it activates ERK/MAPK pathway in oral cancer.Adenosine A2b receptor promotes progression of human oral cancerSemaphorin7A Promotion of Tumoral Growth and Metastasis in Human Oral Cancer by Regulation of G1 Cell Cycle and Matrix Metalloproteases: Possible Contribution to Tumoral Angiogenesis.Down-Regulation of Nucleolar and Spindle-Associated Protein 1 (NUSAP1) Expression Suppresses Tumor and Cell Proliferation and Enhances Anti-Tumor Effect of Paclitaxel in Oral Squamous Cell CarcinomaARNT2 Regulates Tumoral Growth in Oral Squamous Cell Carcinoma.Evidence for Critical Role of Lymphocyte Cytosolic Protein 1 in Oral Cancer.The cytoskeletal protein LASP-1 differentially regulates migratory activities of choriocarcinoma cells.Activin B Regulates Adhesion, Invasiveness, and Migratory Activities in Oral Cancer: a Potential Biomarker for Metastasis.The role of LIM and SH3 protein-1 in bladder cancer metastasis.Lasp2 enhances tumor invasion via facilitating phosphorylation of FAK and predicts poor overall survival of non-small cell lung cancer patients.A seven-gene prognostic signature for rapid determination of head and neck squamous cell carcinoma survival.New Frontiers for the Cytoskeletal Protein LASP1
P2860
Q30009155-676C4485-6A68-487F-8B20-237F581C0DA4Q30009240-46ED412A-466F-4AFB-84CB-783988062D3FQ35003999-57231BA7-2160-4C52-9C72-D4CB49AA6A2FQ35247171-C1B704F5-3B52-4247-A84C-4C0B752FE546Q35602157-3E8C5CD8-BE6A-4935-B23D-85F30E60207BQ35728866-C466969B-4D9A-488D-9EFC-6FBB43ED5A2DQ35778398-3A9D1E4E-A27C-4433-9619-287AA2B1EBC0Q35836951-D95C20CB-7EC3-4587-A95B-9EA0C67092AEQ36792366-14357CE2-0251-4CBC-BCD7-10778F931F3AQ37661304-5418658B-FAAB-4910-9FFF-EB97DFDA2962Q38847335-DB1FA9AE-6931-4764-9412-3D9EED4810DFQ41439877-F2E346FA-3077-4748-B02E-A84C61FCC513Q47139274-1247AC8E-FAA6-4B6E-B4C9-182529EBA726Q48190609-E204BCB1-E44F-4795-B44C-D32A8797E2BDQ49525456-B6D6FE18-0AD8-4939-9938-A065FC880842Q57300047-A08EA0F2-C0F9-4C16-988A-38105C32D080
P2860
Overexpression of LIM and SH3 Protein 1 leading to accelerated G2/M phase transition contributes to enhanced tumourigenesis in oral cancer
description
2013 nî lūn-bûn
@nan
2013 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Overexpression of LIM and SH3 ...... tumourigenesis in oral cancer
@ast
Overexpression of LIM and SH3 ...... tumourigenesis in oral cancer
@en
type
label
Overexpression of LIM and SH3 ...... tumourigenesis in oral cancer
@ast
Overexpression of LIM and SH3 ...... tumourigenesis in oral cancer
@en
prefLabel
Overexpression of LIM and SH3 ...... tumourigenesis in oral cancer
@ast
Overexpression of LIM and SH3 ...... tumourigenesis in oral cancer
@en
P2093
P2860
P3181
P1433
P1476
Overexpression of LIM and SH3 ...... tumourigenesis in oral cancer
@en
P2093
Atsushi Kasamatsu
Dai Nakashima
Fumie Shimizu
Hideki Tanzawa
Katsuhiro Uzawa
Katsunori Ogawara
Masashi Shiiba
Morihiro Higo
Ryota Kimura
Satoshi Yokota
P2860
P304
P3181
P356
10.1371/JOURNAL.PONE.0083187
P407
P577
2013-12-26T00:00:00Z